Toggle navigation
Home
Search
Services
Blog
Contact
About
Cultured Corneal Epithelium - Draize Test Replcement
Klausner, Mitchell
Mattek Corporation, Ashland, MA, United States
Search 31 grants from Mitchell Klausner
Search grants from Mattek Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neurophysiological Assessments of Network Dysfunction in Alzheimer's Disease
Memory and Mental Health in Aging
Modeling the Mechanisms of Protein Folding
Structure and Function of the Adv Genome
POWRE: A Bayesian Approach in Developing Models for the Spatial Variability of Seismic Ground Motions
Recently added grants:
CMA: Cartilage Repair Strategies to Alleviate Arthritic Pain (CaRe AP): Novel cell-based therapies to increase functional outcomes and alleviate pain in preclinical models of osteoarthritis
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
Targeting metabolism in AML
Preoptic/Hypothalamic Mechanisms of Sleep-Wake Regulation
Defining Breath VOC Biomarkers to Improve Respiratory Health of Exposed Veterans
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44ES006670-03
Application #
2155496
Study Section
Special Emphasis Panel (ZRG7-SSS-3 (06))
Project Start
1993-06-01
Project End
1997-06-30
Budget Start
1996-01-01
Budget End
1997-06-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Mattek Corporation
Department
Type
DUNS #
City
Ashland
State
MA
Country
United States
Zip Code
01721
Related projects
NIH 1996
R44 ES
Cultured Corneal Epithelium - Draize Test Replcement
Klausner, Mitchell / Mattek Corporation
NIH 1995
R44 ES
Cultured Corneal Epithelium - Draize Test Replcement
Klausner, Mitchell / Mattek Corporation
Comments
Be the first to comment on Mitchell Klausner's grant